TD Waterhouse Canada Inc. Has $5.49 Million Stock Holdings in HCA Healthcare, Inc. $HCA

TD Waterhouse Canada Inc. trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 12.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,885 shares of the company’s stock after selling 1,853 shares during the period. TD Waterhouse Canada Inc.’s holdings in HCA Healthcare were worth $5,490,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Ameriflex Group Inc. acquired a new stake in HCA Healthcare in the 2nd quarter valued at $27,000. Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $27,000. Clearstead Trust LLC increased its holdings in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares during the period. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $40,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on HCA. Barclays lifted their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research report on Wednesday. Royal Bank Of Canada boosted their target price on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Wednesday. UBS Group boosted their price objective on HCA Healthcare from $525.00 to $598.00 and gave the stock a “buy” rating in a research report on Wednesday. Oppenheimer boosted their target price on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, KeyCorp set a $503.00 price objective on HCA Healthcare in a research report on Wednesday. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $518.76.

HCA Healthcare Stock Performance

HCA stock opened at $488.19 on Friday. The company has a market capitalization of $111.40 billion, a P/E ratio of 17.20, a price-to-earnings-growth ratio of 1.48 and a beta of 1.36. The business has a 50-day simple moving average of $481.07 and a two-hundred day simple moving average of $437.35. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $527.55.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is 10.15%.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Strong quarterly results and market reaction — HCA reported an EPS beat and raised FY 2026 guidance, prompting coverage noting a gap up in the stock after the print. Shares Gap Up on Strong Earnings
• Positive Sentiment: Analysts boost targets and maintain bullish ratings — Goldman Sachs raised its price target to $558 (buy) and Leerink Partners increased its target to $573 (outperform), supporting further upside potential. Goldman Sachs Raises PT Leerink Raises PT TickerReport
• Positive Sentiment: Additional bullish analyst commentary — Truist and Deutsche Bank analysts publicly stated expectations for HCA shares to rise, reinforcing the buy-side momentum. Truist Note Deutsche Bank Note
• Positive Sentiment: Brand and quality recognition — Multiple HCA hospitals placed on Healthgrades’ America’s 50/100/250 Best Hospitals lists, supporting reputation and referral flows. Healthgrades Recognition
• Positive Sentiment: Outpatient growth and M&A runway — Company commentary and industry pieces highlight HCA’s push into outpatient facilities and acquisition opportunities, which investors view as margin‑accretive growth. Outpatient Growth Acquisition Opportunities
• Positive Sentiment: Bullish research notes/coverage — Zacks highlights HCA as a strong growth stock based on style scores, adding to favorable retail/institutional sentiment. Zacks Growth Stock Piece
• Neutral Sentiment: Analysts say the narrative is shifting — Coverage explores how the investment story is evolving post‑earnings/target resets; watch valuation vs. growth expectations. Analyst Narrative
• Neutral Sentiment: Local expansion and competitive landscape — Reporting on new ER builds and regional facility activity (e.g., southwest Florida) that may influence local market share dynamics. Local ER Story Freestanding EDs
• Negative Sentiment: Policy/regulatory risk — HCA is publicly noting it is monitoring federal policy shifts that could affect reimbursement or operations; this is a watcher for downside risk. Policy Risk

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.